Friday, 22 November 2024
  
Login

Australia's most trusted
source of pharma news

Friday, 22 November 2024
News

TGA goes hard with $320K in fines

Posted 15 July 2024 PM

The TGA is playing hardball over unlawful advertising of drugs used off-label for weight loss, issuing 21 infringements to six businesses with fines totalling almost $320,000.

The regulator alleges each of the businesses promoted the use and supply of prescription-only medicines including Novo Nordisk's Ozempic and Saxenda, used for weight loss, and erectile dysfunction drug Viagra, sponsored by Viatris.

To see the whole article, please login

Popular

Top pharmas for women revealed
$80K fine for Aussie Code Breach
Who's trying to dethrone Keytruda?
Senior leaders moving on and up
Latest Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2024 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home